Health Care News
-
The U.S. won’t start a long-term care plan created by the 2010 health overhaul, the largest piece of the law so far to be stopped by Congress, the courts or President Barack Obama’s administration.
-
Bristol-Myers Squibb Co.’s Yervoy drug was rejected by the U.K.’s health-cost agency, which suggested the company consider lowering the price of the skin- cancer treatment.
-
Allos Therapeutics Inc., maker of the blood-cancer drug Folotyn, said it reached a settlement of lawsuits opposing its planned $195 million acquisition by AMAG Pharmaceuticals Inc.
-
Unilever, the world’s second-biggest consumer-goods company, agreed to acquire OAO Concern Kalina in a deal that values the Russian skincare maker at 21.5 billion rubles ($694 million) to tap growth in emerging markets.